Retrospective Analysis to Describe Patient Profiles, Current Treatment Patterns and Economic Burden for Asthma Patients in UAE. A descriptive analysis of the asthma patient population in the Emirate of Dubai with respect to healthcare resource utilization, costs, and asthma-related treatment pattern

Study identifier:D2287R00139

ClinicalTrials.gov identifier:NCT03963141

EudraCT identifier:N/A

CTIS identifier:N/A

Recruiting

Official Title

Retrospective Analysis to Describe Patient Profiles, Current Treatment Patterns and Economic Burden for Asthma Patients in UAE.

Medical condition

asthma

Phase

N/A

Healthy volunteers

No

Study drug

-

Sex

All

Estimated Enrollment

120000

Study type

Observational

Age

N/A

Date

Study Start Date: 07 Mar 2019
Estimated Primary Completion Date: 30 Jun 2022
Estimated Study Completion Date: 30 Jun 2022

Study design

Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Jun 2022 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria